SCHEMBL45583

SCHEMBL45583

C=CCC(O)C(O)(CO)CC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29161650 0.89
SCHEMBL45787 0.75 TSHR (0.32)
SCHEMBL87984 0.75 TSHR (0.32)
SCHEMBL7784750 0.74 CYP2D6 (0.37)
SCHEMBL2874532 0.72 TSHR (0.33)
SCHEMBL1539345 0.72
SCHEMBL10567539 0.71
SCHEMBL28851212 0.71
SCHEMBL23581903 0.68
SCHEMBL23581904 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001044377-A1 COATING COMPOSITION AND NOVEL THIOL INCLUDED THEREIN PERSTORP SPECIALTY CHEMICALS AB (SE) 2001-06-21 WO claimed
JP-4099795-A None JP disclosed
US-12042536-B2 Hepatitis C virus immunogenic compositions and methods of use thereof THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2024-07-23 US disclosed
EP-4355361-A1 HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF Aurora Vaccines, Inc. (CA) 2024-04-24 EP disclosed
CN-117836002-A Hepatitis c virus immunogenic compositions and methods of use thereof 奥罗拉疫苗有限责任公司 2024-04-05 CN disclosed
US-20240058438-A1 HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF Helmholtz Center for Infection Research (DE) 2024-02-22 US disclosed
WO-2022261758-A9 HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF AURORA VACCINES, INC. (CA) 2023-02-23 WO disclosed
US-11576968-B2 Hepatitis C virus immunogenic compositions and methods of use thereof THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2023-02-14 US disclosed
WO-2022261758-A1 HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF AURORA VACCINES, INC. (CA) 2022-12-22 WO disclosed
CN-107613767-B Synergistic preservative composition ISP投资有限公司 2022-06-21 CN disclosed
EP-2868327-A1 NASAL VACCINE AGAINST THE DEVELOPMENT OF ATHEROSCLEROSIS DISEASE AND FATTY LIVER Universidad Nacional Autónoma De México (MX) 2015-05-06 EP disclosed
WO-2012005648-A1 UNSATURATED OLIGIO OR POLYESTER PERSTORP AB (SE) 2012-01-12 WO disclosed
US-20110294933-A1 POLYHYDROXYFUNCTIONAL POLYSILOXANES FOR INCREASING THE SURFACE ENERGY OF THERMOPLASTICS, METHOD FOR PRODUCTION AND USE THEREOF BYK-CHEMIE GMBH (DE) 2011-12-01 US disclosed
US-20060167186-A1 Waterborne copolymer dispersion CELANESE EMULSION NORDEN AB (SE) 2006-07-27 US disclosed
EP-1539895-A1 WATERBORNE COPOLYMER DISPERSION Celanese Emulsions Norden AB (SE) 2005-06-15 EP disclosed
WO-2004016700-A1 WATERBORNE COPOLYMER DISPERSION CELANESE EMULSION NORDEN AB (SE) 2004-02-26 WO disclosed
US-6649780-B1 Useful in preparation of liposomes and other lipid vesicle carriers of nucleic acids and other substances, for delivery to cells VALENTIS, INC. 2003-11-18 US disclosed
JP-H0499795-A PEPTIDE DERIVATIVE FUJI PHOTO FILM CO LTD 1992-03-31 JP disclosed
WO-1991016880-A1 LIPOSOMES WITH POSITIVE EXCESS CHARGE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1991-11-14 WO disclosed
JP-H00499795-A 0001-01-01 JP disclosed